- Posts: 582
- Thank you received: 5
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Moose, why not run the tren and proviron at the end of the cycle to get the maximum effect of those two drugs? After all they're at their most effective then.Something more like this:
Adex: 0.5mg, every day, week 1-16, taper off week 17.
Proviron: 25mg, every day, week 1-4
D-bol: 40mg, every day, week 1-4
Test E: 1ml, 2X per week, week 1-14
Tren Mix: 1ml, 2X per week, week 1-6
EQ: +- 200mg, 2X per week, week 1-14
Winny tab: 50mg, every day, week 13-16
HCG: 500iu, once per week, week 5-14. 500iu second third day weeks 15-16.
Clomid: 100mg, 5 days of week 17. 50mg, last 2 days of week 17 and first 3 days week 18. (10 days total).
Kessar: 20mg, every day, week 18-21.
Compare the 2 and revise yours,
Yours makes no sense to me and the above i believe is too hardcore for someone with your level of knowledge about gear.
Peace.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Before i forget with the masterone, i know it is prone to block estrogen or actually stop conversion do you think letro is still advisable in the beginning of the cycle lets say week 1-10?
Masteron is unaffected by the aromatase and 5alpha-reductase enzymes and therefore there are no issues with estrogen or with potentiation (increase of effect) in tissues such as the skin and prostate. In fact, Masteron is somewhat anti-estrogenic due to competing with estradiol at the estrogen receptor, while not itself activating the receptor, and perhaps by likewise competing with testosterone for the binding site of the aromatase enzyme, thus reducing conversion.
This is a benefit when only a moderate amount of aromatizing steroids are used and no other anti-estrogen is used. It is not, however, sufficient to fully deal with high doses of aromatizing steroids, or at least not with typical doses of Masteron; and is unnecessary when more effective anti-estrogens are employed.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.